Skip to main content
Caplight Logo









IDMED

IDMED

Private
MarseilleHealthcare & Life Scienceshttps://www.idmed.fr/

Last Round

Angel

May 6, 2011

Momentum

Top 25%

of companies Caplight tracks

Company Overview

IDMED operates in Healthcare & Life Sciences and is based in Marseille. Its latest recorded funding round was an Angel round in May 2011.

IDMED is a medical device company that develops and markets innovative monitoring solutions for anesthesia and intensive care, including pupillometry and neuromuscular transmission monitoring devices.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

IDMED Comparables

Compare IDMED with similar companies based on industry and business-model similarity.

IDMED comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RGB Medical Devices S.A.
83%
NeurOptics, Inc.
81%
Xavant Technology
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

IDMED Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelMay 6, 2011
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Thierry BAGNOL

Founder CEO

Founding Team

For institutional investors. Book with your work email.

IDMED Investors

Notable investors and investment history

IDMED investors
InvestorRounds
Provence Business AngelsAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 665% MoM, from 206 to 1.6K.

  • Jun 1, 2025

    Monthly visitors grew 452% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

IDMED Filings

Explore SEC and related filing metadata, where available.

IDMED filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about IDMED's valuation, stock price, and market status.

Is IDMED a public or private company?

IDMED is a private company.

What is the current stock price of IDMED?

IDMED is a private company, so its shares have no public market price. Caplight tracks IDMED's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is IDMED worth (valuation)?

Valuation information for IDMED is not publicly available.

Can I buy IDMED stock?

IDMED shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was IDMED's last funding round?

IDMED's most recent funding round was Angel on May 6, 2011.

Who are the main investors in IDMED?

Key investors in IDMED include Provence Business Angels.

Will IDMED IPO soon?

No public IPO plans have been announced for IDMED.

How can I track IDMED secondary market activity?

Caplight tracks bids, offers, and trades in IDMED's shares on secondary markets.

Firmographic Details

HeadquartersMarseille
Employee Range16
Year Founded2008
Last FundingMay 6, 2011

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?